Omalizumab Reduces Atopic Dermatitis Severity, Improves QOL in Kids Omalizumab Reduces Atopic Dermatitis Severity, Improves QOL in Kids

Omalizumab reduces the severity of atopic dermatitis (AD) in children, though it ' s not clear the improvement is clinically significant, according to a new randomized controlled trial.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news